डुअलिटी बायोलॉजिक्स ने एडसेंडो एपीएस सहयोग का विस्तार किया डुअलिटी बायोलॉजिक्स ने हाल ही में एडसेंडो एपीएस के साथ अपने सहयोग का विस्तार करने की घोषणा की
Category: Antibody Drug Conjugates
MacroGenics Investors Eye Critical 2026 Clinical Milestones
MacroGenics Yatırımcılarının 2026 Klinik Dönüm Noktalarına Dikkati Bioteknoloji yatırımcıları, MacroGenics’in antikor ilaç konjugatları (ADC’ler) ve iki
Precision Engineering Defines Next-Gen ADC
الهندسة الدقيقة تحدد مستقبل عقاقير ADC تعتبر عقاقير الأجسام المضادة المرتبطة بالأدوية (ADCs) فئة متطورة بسرعة من العلاجات المستهدفة في مجال الأورام، حيث
Kelun-Biotech’s SKB103 Gains NMPA Approval: A Leap Forward in Oncology
Kelun Biotech has achieved a significant milestone with the approval of its investigational new drug (IND) application for SKB103, a groundbreaking
The Pivotal Role of Payload Linkers in Advancing Antibody-Drug Conjugates
The evolution of antibody drug conjugates (ADCs) has revolutionized targeted cancer therapy. At the heart of this innovation lies the payload linker, a
Navigating the Complexities of ADC Production
Antibody drug conjugates (ADCs) represent a cutting edge approach in oncology, merging the specificity of antibodies with the therapeutic power of small
Enhanced Radiation Surveillance with Raybird UAS
The landscape of environmental monitoring has taken a significant leap forward with the integration of a radiation sensor payload into the Raybird